Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07680764
PHASE2

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the safety, tolerability, and efficacy of Imzokitug in combination with Pumitamig and Platinum-Doublet Chemotherapy (PDCT) versus Pumitamig and PDCT as first-line treatment for participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Official title: A Phase 2, Randomized, Open-label, Study Assessing the Safety, Tolerability and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2026-09-10

Completion Date

2030-09-15

Last Updated

2026-10-02

Healthy Volunteers

No

Interventions

DRUG

Pumitamig

Specified dose on specified days

DRUG

Imzokitug

Specified dose on specified days

DRUG

Pemetrexed

Specified dose on specified days

DRUG

Cisplatin

Specified dose on specified days

DRUG

Carboplatin

Specified dose on specified days

DRUG

Paclitaxel

Specified dose on specified days

Locations (73)

Local Institution - 0183

Washington D.C., District of Columbia, United States

University Cancer & Blood Center, LLC

Athens, Georgia, United States

Local Institution - 0034

Lexington, Kentucky, United States

Local Institution - 0171

Lexington, Kentucky, United States

Local Institution - 0123

Baltimore, Maryland, United States

Local Institution - 0180

Hattiesburg, Mississippi, United States

Nebraska Cancer Specialists

Grand Island, Nebraska, United States

Oncology Hematology West PC

Omaha, Nebraska, United States

Local Institution - 0080

New York, New York, United States

Local Institution - 0176

Columbus, Ohio, United States

Local Institution - 0095

Houston, Texas, United States

Local Institution - 0135

Madison, Wisconsin, United States

Sanatorio Parque Rosario

Rosario, Santa Fe Province, Argentina

Instituto Medico Especializado Alexander Fleming

Buenos Aires, Argentina

Clinica Viedma S.A.

Viedma, Argentina

Local Institution - 0074

Gosford, New South Wales, Australia

Local Institution - 0134

Westmead, New South Wales, Australia

Local Institution - 0167

Greenslopes, Queensland, Australia

Local Institution - 0100

Heidelberg, Victoria, Australia

St. John of God Murdoch Hospital

Perth, Western Australia, Australia

Local Institution - 0003

Natal/RN, Rio Grande do Norte, Brazil

Local Institution - 0006

Porto Alegre, Rio Grande do Sul, Brazil

Local Institution - 0005

Barretos, São Paulo, Brazil

Local Institution - 0001

São Paulo, Brazil

Local Institution - 0081

Santiago, Santiago Metropolitan, Chile

Local Institution - 0149

Santiago, Santiago Metropolitan, Chile

Local Institution - 0084

Viña del Mar, Valparaiso, Chile

Local Institution - 0038

Beijing, Beijing Municipality, China

Local Institution - 0138

Fuzhou, Fujian, China

Local Institution - 0050

Wuhan, Hubei, China

Local Institution - 0147

Nanjing, Jiangsu, China

Local Institution - 0140

Shanghai, Shanghai Municipality, China

Local Institution - 0169

Shanghai, Shanghai Municipality, China

Local Institution - 0144

Chengdu, Sichuan, China

Local Institution - 0137

Hangzhou, Zhejiang, China

Local Institution - 0131

Nice, Alpes-Maritimes, France

Local Institution - 0087

Montpellier, Languedoc-Roussillon, France

Local Institution - 0119

Villejuif, Val-de-Marne, France

Local Institution - 0047

Grenoble, France

Assistance Publique Hôpitaux de Marseille - Hôpital Nord

Marseille, France

Local Institution - 0109

Paris, France

Local Institution - 0085

Saint-Herblain, France

Local Institution - 0019

Paris, Île-de-France Region, France

Robert Bosch Krankenhaus

Stuttgart, Baden-Wurttemberg, Germany

Local Institution - 0156

Marburg, Hesse, Germany

Local Institution - 0152

Homburg, Saarland, Germany

Local Institution - 0065

Cologne, Germany

Christliches Klinikum Halle (Saale) GmbH

Haile, Germany

Local Institution - 0125

Hessen, Germany

Local Institution - 0128

Misterbianco, Catania, Italy

Local Institution - 0043

Bari, Italy

Local Institution - 0148

Bergamo, Italy

Local Institution - 0159

Milan, Italy

Local Institution - 0014

Ravenna, Italy

Local Institution - 0011

Rozzano (MI), Italy

Local Institution - 0114

Florești, Cluj, Romania

Local Institution - 0113

Timișoara, Timiș County, Romania

Local Institution - 0076

Bucharest, Romania

Institutul Oncologic Cluj

Cluj-Napoca, Romania

Centrul de Oncologie Sf. Nectarie SRL

Craiova, Romania

Victoria Hospital (Centrul de oncologie Euroclinic SRL) (Centrul De Oncologie Medicala) (Euroclinic Onchology Center)

Iași, Romania

Institutul Regional de Oncologie Iasi

Iași, Romania

Local Institution - 0132

Badalona, Barcelona, Spain

Local Institution - 0162

Seville, Seville, Spain

Local Institution - 0027

Barcelona, Spain

Local Institution - 0068

Barcelona, Spain

Local Institution - 0163

Barcelona, Spain

Local Institution - 0041

Madrid, Spain

Local Institution - 0010

Majadahonda, Spain

Hospital Carlos Haya De Malaga

Málaga, Spain

Local Institution - 0182

Birmingham, BIR, United Kingdom

Local Institution - 0035

London, Greater London, United Kingdom

The Royal Surrey County Hospital NHS Foundation Trust

Guildford, United Kingdom